Exelixis (NASDAQ:EXEL) Price Target Raised to $47.00 at HC Wainwright
Exelixis (NASDAQ:EXEL – Free Report) had its price objective lifted by HC Wainwright from $40.00 to $47.00 in a report released on Thursday morning,Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. Other research analysts also recently issued reports about the stock. Piper Sandler boosted their price objective on shares of […]
Exelixis (NASDAQ:EXEL – Free Report) had its price objective lifted by HC Wainwright from $40.00 to $47.00 in a report released on Thursday morning,Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. Other research analysts also recently issued reports about the stock. Piper Sandler boosted their price objective on shares of […]
